Our Background

Our Story

CAScination AG is an award-winning medical technology company dedicated to the development, manufacturing and commercialization of innovations in computer-assisted and image-guided surgery. Our trailblazing navigation systems and surgical robots are designed to improve outcomes for patients undergoing surgical or interventional procedures and offer new perspectives to patients worldwide. Our CAS-One planning and navigation system is used to treat patients suffering from soft tissue cancer (e.g., liver cancer) by many hospitals across Europe, and we are developing further applications in a number of disease areas. 

Our CAS-One planning and navigation system is CE marked and FDA cleared, and is used by many hospitals across the world.  We are continually expanding our technology to new treatment areas where precision navigation can help to improve outcomes.

Cascination facts


Published clinical papers


Countries using CAS-One Technology


Centres using the technology


Procedures performed

Our Mission

Our mission is to improve outcomes in medical interventions, by establishing CAS-One robotics and navigation technology as standard-of care.  We aim to provide physicians with the tools needed to ensure precise, reproducible and efficient therapy, and give patients access to minimally invasive and effective treatments, helping them to recover fast and get back to enjoying life.

Our history


Winner Swiss Medtech Award


US and European expansion


FDA clearance


Winner CTI Swiss Medtech Award


CE Mark granted


Company founded as spin-off from ARTORG


Winner Swiss Medtech Award 2019
Handelszeitung Wachstums-Champion (11th Rank) 2017
Finalist Swiss Economic Award 2015
Venture Kick Best Video Award 2014
Ypsomed Innovationspreis 2013
Winner CTI Swiss Medtech Award 2013
Jungunternehmerpreis 2011
W.A. de Vigier Entrepreneurship Prize 2011
Finalist Swiss Technology Award 2011
CTI Start-up Label 2010